A detailed history of Cornerstone Advisors Asset Management, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cornerstone Advisors Asset Management, Inc holds 2,500 shares of ABBV stock, worth $432,550. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,500
Holding current value
$432,550
% of portfolio
0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $409,600 - $498,325
2,500 New
2,500 $494 Million
Q3 2023

Nov 19, 2024

SELL
$133.59 - $154.65 $3,339 - $3,866
-25 Reduced 0.99%
2,500 $373 Million
Q2 2023

Nov 19, 2024

BUY
$132.51 - $164.9 $927 - $1,154
7 Added 0.28%
2,525 $340 Million
Q1 2023

Nov 19, 2024

BUY
$144.61 - $166.54 $2,602 - $2,997
18 Added 0.72%
2,518 $401 Million
Q3 2022

Nov 19, 2024

BUY
$134.21 - $153.93 $2,415 - $2,770
18 Added 0.72%
2,518 $338 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cornerstone Advisors Asset Management, Inc Portfolio

Follow Cornerstone Advisors Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors Asset Management, Inc with notifications on news.